- Current report filing (8-K)
February 24 2009 - 4:00PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest
event reported): February 20, 2009
CERADYNE, INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
000-13059
|
|
33-0055414
|
(State or other Jurisdiction of Incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer Identification No.)
|
|
|
|
3169 Red Hill Avenue, Costa
Mesa, CA
|
|
92626
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
Registrant’s telephone number,
including area code:
(714) 549-0421
|
|
(Former name or former address if changed since last report.)
|
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:
o
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
1
Item 7.01 Regulation FD Disclosure.
On February 20, 2009, Ceradyne, Inc. issued a press release announcing that it has received a
$12.1 million order for ESAPI (Enhanced Small Arms Protective Inserts) issued by the Defense Supply
Center Philadelphia. A copy of this press release is being furnished as Exhibit 99.1 to this
Current Report on Form 8-K.
In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report
on Form 8-K, including Exhibit 99.1, shall not be deemed filed for the purposes of Section 18 of
the Securities Exchange Act of 1934 or otherwise subject to the liability of that section, nor
shall it be deemed incorporated by reference in any filing under the Securities Act of 1933.
Item 9.01 Financial Statements and Exhibits.
|
|
|
|
|
Exhibit Number
|
|
Description
|
|
99.1
|
|
|
Press release of Ceradyne, Inc. dated February 20, 2009.
|
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
CERADYNE, INC.
|
|
February 24, 2009
|
By:
|
/s/ Jerrold J. Pellizzon
|
|
|
|
Jerrold J. Pellizzon
|
|
|
|
Chief Financial Officer and Secretary
|
|
3
EXHIBIT INDEX
|
|
|
|
|
Exhibit Number
|
|
Description
|
|
99.1
|
|
|
Press release of Ceradyne, Inc. dated February 20, 2009.
|
4
Ceradyne, Inc. (MM) (NASDAQ:CRDN)
Historical Stock Chart
From May 2024 to Jun 2024
Ceradyne, Inc. (MM) (NASDAQ:CRDN)
Historical Stock Chart
From Jun 2023 to Jun 2024